NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, an established leader in the development of innovative, proven, and trusted weight loss experiences, today announced the Premarket Approval (PMA) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Adults with obesity who received a novel gastric balloon ...

Allurion Technologies has launched its ENLIGHTEN clinical study of Elipse, a weight loss balloon swallowed via capsule and filled with liquid through a catheter, thereby avoiding surgery for patients ...

NATICK, Mass.--(BUSINESS WIRE)--Allurion, a company dedicated to ending obesity, today announced results from a new study that will be presented at the European Congress on Obesity exploring the use ...

A new treatment for overweight and obesity combining the world’s first and only procedureless swallowable gastric balloon—that is placed without surgery, endoscopy or anaesthesia and passes out of the ...

Intragastric balloons are temporary, non-surgical weight-loss devices placed in the stomach to reduce gastric capacity. These devices are used in adults who are overweight or suffer from obesity and ...

DUBLIN — A swallowable gastric balloon (Allurion Balloon, formerly known as Elipse) combined with daily subcutaneous injections of the glucagon-like peptide 1 (GLP-1) agonist liraglutide (Saxenda, ...